Singlera Genomics raises $150 million in Series B financing to promote the development and commercialization of early cancer screening products
Bionano Genomics Acquires Diagnostics Services Provider Lineagen, Inc. to Accelerate Clinical Adoption of Saphyr for Digital Cytogenetics